Sarah Kean

Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.

A. Talhouk, S. Leung, D. Huntsman, 2022, Gynecologic oncology.

Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019

K. McManus, M. Nachtigal, K. Decker, 2022, Current oncology.

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.

A. Talhouk, S. Leung, D. Huntsman, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.

A. Talhouk, S. Leung, D. Huntsman, 2023, Gynecologic oncology.

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

A. Talhouk, S. Leung, A. Tinker, 2022, Modern Pathology.

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk‐reducing surgical decision‐making practices: A mixed‐methods study

K. McManus, J. N. Hartley, M. Nachtigal, 2023, Journal of genetic counseling.

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin

A. Altman, Sarah Kean, B. Hosseini, 2017, Gynecologic Oncology Reports.

Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations

C. Bouchard, J. Bentley, Nicole Todd, 2023, Current oncology.

Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer.

M. Nachtigal, A. Altman, C. Robinson, 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.